Biznesradar bez reklam? Sprawdź BR Plus
Wiadomości INC
1.520+0.005(+0.33%)INC SPÓŁKA AKCYJNA
GPW - Akcje/PDA - Notowania ciągłe
Biznesradar bez reklam? Sprawdź BR Plus
Teradyne, Inc. surged 5.6% on Tuesday to $385.60 as a broad rally swept across the semiconductor equipment sector, lifting the company alongside four peers p...
The post Teradyne Jumps 5.6% Amid Sector-Wide Rally first appeared on Alphastreet.
Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC) surged 5.5% on Tuesday, August 11, 2026, closing at $91.25 as a broad rally swept through semiconductor equi...
The post Kulicke and Soffa Industries Jumps 5.5% Amid Sector-Wide Rally first appeared on Alphastreet.
908 Devices Inc.
The post 908 Devices Releases Q2 2026 Financial Results first appeared on Alphastreet.
Chicago Atlantic Real Estate Finance, Inc. (REFI) posted Q2 2026 diluted distributable earnings EPS of $0.43, falling short of the $0.44 estimate (miss ...
The post Chicago Atlantic Real Estate Finance (REFI) Reports Q2 2026 Numbers first appeared on Alphastreet.
Arq, Inc.
The post Arq Releases Q2 2026 Financial Results first appeared on Alphastreet.
Barnwell Industries, Inc.
The post Barnwell Industries Releases Q3 2026 Financial Results first appeared on Alphastreet.
Alico, Inc.
The post Alico Releases Q3 2026 Financial Results first appeared on Alphastreet.
Aura Biosciences, Inc.
The post Aura Biosciences Releases Q2 2026 Financial Results first appeared on Alphastreet.
Janus International Group, Inc.
The post Janus International Group Releases Q2 2026 Financial Results first appeared on Alphastreet.
Broadwind, Inc. (BWEN) reported Q2 2026 basic and diluted loss of $0.03 per share, a wider loss than the -$0.01 estimate (200.0% wider).
The post Broadwind Releases Q2 2026 Financial Results first appeared on Alphastreet.
Q2 2026 basic and diluted earnings at Kayne Anderson BDC, Inc. (KBDC) came in at $0.16 per share, trailing the $0.41 consensus (miss by 61.0%).
The post Kayne Anderson BDC Releases Q2 2026 Financial Results first appeared on Alphastreet.
DiaMedica Therapeutics Inc.
The post DiaMedica Therapeutics Releases Q2 2026 Financial Results first appeared on Alphastreet.
Mistras Group, Inc.
The post Mistras Group Releases Q2 2026 Financial Results first appeared on Alphastreet.
Team, Inc.
The post Team Releases Q2 2026 Financial Results first appeared on Alphastreet.
Xtant Medical Holdings, Inc. (XTNT) posted a Q2 2026 Non-GAAP adjusted loss of $0.02 per share, narrower than the -$0.02 expected loss (0.0% narrower).
The post Xtant Medical Holdings Releases Q2 2026 Financial Results first appeared on Alphastreet.
Gain Therapeutics, Inc.
The post Gain Therapeutics Releases Q2 2026 Financial Results first appeared on Alphastreet.
Tango Therapeutics, Inc.
The post Tango Therapeutics Releases Q2 2026 Financial Results first appeared on Alphastreet.
Imunon, Inc.
The post Imunon Releases Q2 2026 Financial Results first appeared on Alphastreet.
James River Group Holdings, Inc. (JRVR) posted Q2 2026 adjusted net operating income EPS of $0.20, falling short of the $0.25 estimate (miss by 20.0%).
The post James River Group Holdings Releases Q2 2026 Financial Results first appeared on Alphastreet.
ECARX Holdings Inc.
The post ECARX Holdings Releases Q2 2026 Financial Results first appeared on Alphastreet.
Biznesradar bez reklam? Sprawdź BR Plus
Biznesradar bez reklam? Sprawdź BR Plus
Informacje
| ISIN: | PLINCLT00015 |
|---|---|
| Data debiutu: | 09.08.2006 |
| Liczba akcji: | 15 043 099 |
| Kapitalizacja: | 22 865 510 |
| Enterprise Value: | 22 478 510 |
| Branża: | Działalność inwestycyjna |
INC funkcjonuje w obszarze inwestycji oraz doradztwa na rynku kapitałowym. Spółka specjalizuje się w pomocy i wsparciu małym i średnim spółkom... INC funkcjonuje w obszarze inwestycji oraz doradztwa na rynku kapitałowym. Spółka specjalizuje się w pomocy i wsparciu małym i średnim spółkom działającym w różnych sektorach. Poza prywatnymi przedsiębiorstwami, INC świadczy również usługi doradcze jednostkom samorządu terytorialnego oraz angażuje się w projekty sportowe, kulturalne i akademickie.
Biznesradar bez reklam? Sprawdź BR Plus
